A 6-month parallel group, randomized, investigator-blind, placebo-controlled, multicenter proof of concept trial comparing the efficacy of E25 to that of placebo in the treatment of moderate to severe atopic dermatitis in subjects 6-16

(PI: McCall, Co-I: Chen) 1% effort <10 subjects

Awarded By

  • Novartis

Contributors

Amount

  • $30,000.00

Start/End

  • August 1, 1998 - January 31, 2002